ABSTRACT
Purpose
To study the impact of different process conditions and formulation compositions on metastable mannitol forms in protein formulations during lyophilization.
Methods
Mannitol was studied with and without other formulation components. A cryostage was used to mimic the different processing steps during lyophilization. The different mannitol forms were monitored and quantified with an in situ Raman spectroscopic method. In addition, a Raman imaging method was developed to characterize the spatial distribution of mannitol forms in final lyophilization samples from the freeze-drying stage.
Results
Amorphous mannitol was observed during fast cooling (10°C/min) and with the addition of other formulation component. Amorphous mannitol crystallized into mainly δ and hemihydrate forms during annealing at −20°C. Under vacuum without moisture, dried amorphous mannitol could transform to mainly α form at 45°C and greater. The transformation mechanism of the hemihydrate mannitol was similar to that of amorphous form.
Conclusion
Mannitol tends to crystallize into stable crystalline forms by itself, but the addition of lyoprotectant (e.g. sucrose) and protein helps stabilize the metastable forms (hemihydrate and amorphous). The metastable forms are capable of transforming into mixtures of different forms, with heat and moisture being the critical processing factors.
Similar content being viewed by others
REFERENCES
Izutsu K, Yoshioka S, Terao T. Decreased protein-stabilizing effects of cryoprotectants due to crystallization. Pharm Res. 1993;10(8):1232–7.
Izutsu K, Yoshioka S, Terao T. Effect of mannitol crystallinity on the stabilization of enzymes during freeze-drying. Chem Pharm Bull. 1994;42(1):5–8.
Johnson RE, Kirchhoff CF, Gaud HT. Mannitol-sucrose mixtures-versatile formulations for protein lyophilization. J Pharm Sci. 2002;91(4):914–22.
Cleland JL, Lam X, Kendrick B, Yang J, Yang T, Overcashier D, et al. A specific molar ratio of stabilizer to protein is required for storage stability of a lyophilized monoclonal antibody. J Pharm Sci. 2001;90(3):310–21.
Burger A, Henck JO, Hetz S, Rollinger JM, Weissnicht AA, Stottner H. Energy/temperature diagram and compression behavior of the polymorphs of D-mannitol. J Pharm Sci. 2000;89(4):457–68.
Yu L, Milton N, Groleau EG, Mishra DS, Vansickle RE. Existence of a mannitol hydrate during freeze-drying and practical implications. J Pharm Sci. 1999;88(2):196–8.
Nunes C, Suryanarayanan R, Botez C, Stephens PW. Characterization and crystal structure of D-mannitol hemihydrate. J Pharm Sci. 2004;93(11):2800–9.
Cao W, Mao C, Chen W, Lin H, Krishnan S, Cauchon N. Differentiation and quantitative determination of surface and hydrate water in lyophilized mannitol using NIR spectroscopy. J Pharm Sci. 2006;95(9):2077–86.
Kim AI, Akers MJ, Nail SL. The physical state of mannitol after freeze-drying: effects of mannitol concentration, freezing rate, and a noncrystallizing cosolute. J Pharm Sci. 1998;87(8):931–5.
Telang C, Yu L, Suryanarayanan R. Effective inhibition of mannitol crystallization in frozen solutions by sodium chloride. Pharm Res. 2003;20(4):660–7.
Cavatur RK, Vemuri NM, Pyne A, Chrzan Z, Toledo-Velasquez D, Suryanarayanan R. Crystallization behavior of mannitol in frozen aqueous solutions. Pharm Res. 2002;19(6):894–900.
Shalaev EY, Zografi G. How does residual water affect the solid-state degradation of drugs in the amorphous state? J Pharm Sci. 1996;85(11):1137–41.
Liu WR, Langer R, Klibanov M. Moisture-induced aggregation of lyophilized proteins in the solid state. Biotechnol Bioeng. 1991;37:177–84.
Breen ED, Curley JG, Overcashier DE, Hsu CC, Shire SJ. Effect of moisture on the stability of a lyophilized humanized monoclonal antibody formulation. Pharm Res. 2001;18(9):1345–53.
Pikal MJ, Dellerman K, Roy ML. Formulation and stability of freeze-dried proteins: effects of moisture and oxygen on the stability of freeze-dried formulations of human growth hormone. Dev Biol Standard. 1991;74:21–38.
Dixon D, Tchessalov S, Barry A, Warne N. The impact of protein concentration on mannitol and sodium chloride crystallinity and polymorphism upon lyophilization. J Pharm Sci. 2009;98(9):3419–29.
Liao X, Krishnamurthy R, Suryanarayanan R. Influence of the active pharmaceutical ingredient concentration on the physical state of mannitol -implications in freeze-drying. Pharm Res. 2005;22(11):1978–85.
Liao X, Krishnamurthy R, Suryanarayanan R. Influence of processing conditions on the physical state of mannitol-implications in freeze-drying. Pharm Res. 2007;24(2):370–6.
Beattie JR, Barrett LJ, Malone JF, McGarvey JJ, Nieuwenhuyzen M, Kett VL. Investigation into the subambient behavior of aqueous mannitol solutions using temeprature-controlled Raman microscopy. Eur J Pharm Biopharm. 2007;67(2):569–78.
Xie Y, Cao W, Krishnan S, Lin H, Cauchon N. Characterization of mannitol polymorphic forms in lyophilized protein formulations using a Multivariate Curve Resoultion (MCR)-based Raman spectroscopic method. Pharm Res. 2008;25(10):2292–301.
Bhargava R, Schaeberle MD, Levin IW. Raman and mid-infrared microspectroscopic imaging. In: Braiman MS, Gregoriou VG, editors. Vibrational spectroscopy of biological and polymeric materials. CRC Press; 2006. p. 215–52.
Markwort L, Kip B. Micro-Raman imaging of heterogeneous polymer systems: general applications and limitations. J Appl Polym Sci. 1996;61(2):231–54.
Turner II JF, Treado PJ. LCTF Raman chemical imaging in the near-infrared. Proc SPIE. 1997;3061:280–3.
Cavatur RK, Suryanarayanan R. Characterization of phase transitions during freeze-drying by in situ X-ray powder diffractometry. Pharm Dev Technol. 1998;3(4):579–86.
Yu L, Mishra DS, Rigsbee DR. Determination of the glass properties of D-mannitol using sorbitol as an impurity. J Pharm Sci. 1998;87(6):774–7.
ACKNOWLEDGMENTS AND DISCLOSURES
The authors thank Nina Cauchon for discussion and the summer intern program at Amgen Inc. for funding.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cao, W., Xie, Y., Krishnan, S. et al. Influence of Process Conditions on the Crystallization and Transition of Metastable Mannitol Forms in Protein Formulations During Lyophilization. Pharm Res 30, 131–139 (2013). https://doi.org/10.1007/s11095-012-0855-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-012-0855-9